Diagnostic Pathology Clinic, Pathos Tsutsumi, 1551-1 Sankichi-ato, Yawase-cho, Inazawa 492-8342, Aichi, Japan.
Specially Appointed Professor, School of Medical Technology, Yokkaichi Nursing and Medical Care University, 1200 Kayou-cho, Yokkaichi 512-8045, Mie, Japan.
Cells. 2021 Jun 15;10(6):1501. doi: 10.3390/cells10061501.
Chromogenic immunohistochemistry (immunostaining using an enzyme-labeled probe) is an essential histochemical technique for analyzing pathogenesis and making a histopathological diagnosis in routine pathology services. In neoplastic lesions, immunohistochemistry allows the study of specific clinical and biological features such as histogenesis, behavioral characteristics, therapeutic targets, and prognostic biomarkers. The needs for appropriate and reproducible methods of immunostaining are prompted by technical development and refinement, commercial availability of a variety of antibodies, advanced applicability of immunohistochemical markers, accelerated analysis of clinicopathological correlations, progress in molecular targeted therapy, and the expectation of advanced histopathological diagnosis. However, immunostaining does have various pitfalls and caveats. Pathologists should learn from previous mistakes and failures and from results indicating false positivity and false negativity. The present review article describes various devices, technical hints, and trouble-shooting guides to keep in mind when performing immunostaining.
显色免疫组织化学(使用酶标记探针的免疫染色)是分析发病机制和在常规病理服务中进行组织病理学诊断的重要组织化学技术。在肿瘤病变中,免疫组织化学允许研究特定的临床和生物学特征,如组织发生、行为特征、治疗靶点和预后生物标志物。免疫染色的适当和可重复方法的需求是由技术发展和改进、各种抗体的商业可用性、免疫组织化学标记物的高级适用性、临床病理相关性的加速分析、分子靶向治疗的进展以及高级组织病理学诊断的期望所推动的。然而,免疫染色确实存在各种陷阱和注意事项。病理学家应该从以往的错误和失败中吸取教训,并从表明假阳性和假阴性的结果中吸取教训。本文综述了各种设备、技术提示和故障排除指南,以在进行免疫染色时牢记在心。